| Bernardo J Selim, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Bernardo J Selim |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174501423 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Mayo Clinic Health System In Red Wing | Red wing, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164463659 PECOS PAC ID: 1951213487 Enrollment ID: O20031104000095 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bernardo J Selim, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Bernardo J Selim, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
This study compares ER performance at safety-net hospitals (those with a disproportionate share of Medicaid and uninsured patients) to non-safety net hospitals to see if proposed pay-for-performance measures could have a negative impact.
The U.S. Food and Drug Administration will hold a public meeting on April 12, 2010, to obtain comments on the Prescription Drug User Fee Act program. The program authorizes user fees for FDA product reviews, which currently fund more than half of new drug review costs.
› Verified 1 days ago
Emily Leasure, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jorge A Velosa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michael Ruediger Mueller, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mr. Karun Singh Badwal, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michal Reid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Katherine Desprez Wick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Allison Bock, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |